Latest Advances

  • Condition: Child with Refractory Systemic Juvenile Idiopathic Arthritis (SIJA)
  • Journal: Pediatric rheumatology online journal
  • Treatment Used: Haploidentical Bone Marrow Transplantation (HSCT)
  • Number of Patients: 1
  • Published —
This case report describes a 15-month-old girl diagnosed with refractory systemic juvenile idiopathic (of unknown cause) arthritis (SJIA) treated with haploidentical bone marrow transplantation (HSCT).
  • Condition: Juvenile Idiopathic Arthritis
  • Journal: Indian pediatrics
  • Treatment Used: Non-Steroidal Anti-Inflammatory Drugs
  • Number of Patients: 1112
  • Published —
The study compared the outcomes of non-steroidal anti-inflammatory drugs for treating juvenile idiopathic arthritis (JIA).
  • Condition: Juvenile Idiopathic Arthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Etanercept
  • Number of Patients: 2725
  • Published —
In this study, researchers evaluated the long-term safety and effectiveness of etanercept for the treatment of juvenile idiopathic arthritis.
  • Condition: Pregnant Women with Uveitis
  • Journal: Clinical and experimental rheumatology
  • Treatment Used: Certolizumab Pegol (CZP)
  • Number of Patients: 14
  • Published —
This study assessed the safety and effectiveness of certolizumab pegol in pregnant women with uveitis (eye inflammation).
  • Condition: Systemic or Polyarticular-Course Juvenile Idiopathic Arthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Tocilizumab
  • Number of Patients: 188
  • Published —
This study tested the safety and efficacy of using tocilizumab to treat patients with systemic or polyarticular-course juvenile idiopathic arthritis.
  • Condition: Juvenile Idiopathic Arthritis
  • Journal: Journal of investigative medicine high impact case reports
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 1
  • Published —
This article described a patient with juvenile idiopathic arthritis (conditions involving joint inflammation that first appears before the age of 16) treated with hydroxychloroquine (medication used to prevent and treat malaria) who developed chronic hypoxic respiratory myopathy.
  • Condition: Juvenile Idiopathic Arthritis
  • Journal: Pediatric rheumatology online journal
  • Treatment Used: Prefilled Pen Versus Prefilled Syringe of Methotrexate
  • Number of Patients: 23
  • Published —
In this study, researchers compared the outcomes of using a pre-filled pen versus a pre-filled syringe of methotrexate for the treatment of juvenile idiopathic arthritis.
  • Condition: Pediatric Noninfectious Uveitis
  • Journal: Korean journal of ophthalmology : KJO
  • Treatment Used: Adalimumab
  • Number of Patients: 12
  • Published —
The study researched the outcomes of adalimumab in treating pediatric noninfectious uveitis.
  • Condition: Children with Rheumatic Diseases During COVID-19 Pandemic
  • Journal: Rheumatology international
  • Treatment Used: Immunosuppressive Treatment
  • Number of Patients: 853
  • Published —
This study sought determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease 2019 (COVID-19) poses a risk for children with rheumatic diseases on immunosuppressive treatment.
  • Condition: Adolescents With Juvenile Idiopathic Arthritis (JA)
  • Journal: Journal of medical Internet research
  • Treatment Used: Web-Based Self-Management Program With Telephone Support
  • Number of Patients: 333
  • Published —
This study evaluated the effectiveness of the Teens Taking Charge Web-based self-management intervention in reducing symptoms and improving health-related quality of life (HRQL) in adolescents with juvenile idiopathic arthritis (JIA).
  • Condition: Polyarticular Juvenile Idiopathic Arthritis
  • Journal: RMD open
  • Treatment Used: Adalimumab with or without Methotrexate
  • Number of Patients: 171
  • Published —
The study researched the outcomes of adalimumab with or without methotrexate for polyarticular juvenile idiopathic arthritis.
Showing 1-12 of 69